Efavirenz
Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in HIV-1 research. It potently inhibits viral replication in vitro and is widely employed to study antiretroviral mechanisms, drug resistance, and complex cytochrome P450-mediated metabolic interactions.
Product Specifications
CAS Number
154598-52-4
Product Name Alternative
EFV, Efavirenz, L743726, L-743726, HIVProtease, HIV-1 RT, HIV Protease, HIV, Inhibitor, Human immunodeficiency virus, L 743726, inhibit, Autophagy, DMP 266, DMP266, DMP-266, ReverseTranscriptase, Reverse Transcriptase, Stocrin, Sustiva
Field of Research
Cell Biology, Infectious Disease & Virology, Metabolism Research, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
99.20% (May vary between batches)
Solubility
Methanol:10 mM; H2O:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:250 mg/mL (791.97 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.34 mM)
Smiles
C (#CC1CC1) [C@@]2 (C (F) (F) F) C=3C (NC (=O) O2) =CC=C (Cl) C3
Molecular Formula
C14H9ClF3NO2
Molecular Weight
315.67
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
G8140-01H 1 mg
Glyceraldehyde 3 Phosphate Dehydrogenase (GAPDH, glyceraldehyde-3-phosphate dehydrogenase, HGNC:4141, G3PD, GAPD, MGC88685) discontinued
Sign In for Pricing
View Details 
